Since then, LBH has received attention as a new tumor-associated gene, and its role in nasopharyngeal carcinoma (Liu et al., 2015), hepatocellular carcinoma (Chen et al., 2018), prostate cancer (Liu et al., 2018), and lung adenocarcinoma (Deng et al., 2018) has been studied. This evidence concerns the gene LBH and nasopharyngeal carcinoma.